Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 148
9
Diseases
51
Unique genes
0.139
Avg. similarity score
Hemochromatosis
Most-connected disease (7 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Hemochromatosis
Digenic hemochromatosis
Beta thalassemia
Hereditary hemochromatosis
hemochromatosis type 2B
hemochromatosis type 3
Iron metabolism disorder
hemochromatosis type 2A
lessel-kreienkamp syndrome
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Hemochromatosis | 7 | 7 | 14 |
| Digenic hemochromatosis | 6 | 6 | 4 |
| Beta thalassemia | 5 | 5 | 21 |
| Hereditary hemochromatosis | 5 | 5 | 7 |
| hemochromatosis type 2B | 4 | 4 | 1 |
| hemochromatosis type 3 | 4 | 4 | 1 |
| Iron metabolism disorder | 2 | 2 | 22 |
| hemochromatosis type 2A | 2 | 2 | 1 |
| lessel-kreienkamp syndrome | 1 | 1 | 1 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| HAMP | 5 / 9 | Beta thalassemia, Digenic hemochromatosis, Hemochromatosis, hemochromatosis type 2B and 1 more |
| HFE | 5 / 9 | Beta thalassemia, Digenic hemochromatosis, Hemochromatosis, Hereditary hemochromatosis and 1 more |
| TFR2 | 5 / 9 | Beta thalassemia, Digenic hemochromatosis, Hemochromatosis, hemochromatosis type 3 and 1 more |
| HJV | 3 / 9 | Digenic hemochromatosis, Hemochromatosis, hemochromatosis type 2A |
| AGO2 | 2 / 9 | Iron metabolism disorder, lessel-kreienkamp syndrome |
| BMP2 | 2 / 9 | Hemochromatosis, Iron metabolism disorder |
| CP | 2 / 9 | Hemochromatosis, Iron metabolism disorder |
| FTH1 | 2 / 9 | Hemochromatosis, Iron metabolism disorder |
| SLC40A1 | 2 / 9 | Hemochromatosis, Hereditary hemochromatosis |
| TFRC | 2 / 9 | Beta thalassemia, Iron metabolism disorder |
| TNF | 2 / 9 | Beta thalassemia, Hemochromatosis |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Iron uptake and transport | Reactome | 10 / 28 | 84.1× | 9.25e-18 | 5.01e-15 ✓ sig. |
| Ferroptosis | KEGG | 8 / 42 | 44.9× | 6.30e-12 | 1.17e-9 ✓ sig. |
| Mineral absorption | KEGG | 8 / 61 | 30.9× | 1.48e-10 | 2.06e-8 ✓ sig. |
| TGF-beta signaling pathway | KEGG | 9 / 108 | 19.6× | 6.09e-10 | 7.18e-8 ✓ sig. |
| Porphyrin metabolism | KEGG | 6 / 46 | 30.7× | 3.56e-8 | 2.65e-6 ✓ sig. |
| Metal ion SLC transporters | Reactome | 4 / 9 | 105× | 3.58e-8 | 2.66e-6 ✓ sig. |
| Pyrimidine biosynthesis | Reactome | 3 / 3 | 235× | 7.21e-8 | 4.92e-6 ✓ sig. |
| Transferrin endocytosis and recycling | Reactome | 4 / 31 | 30.4× | 8.34e-6 | 2.88e-4 ✓ sig. |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (macrophages) | Reactome | 2 / 2 | 235× | 1.77e-5 | 5.40e-4 ✓ sig. |
| Defective CP causes aceruloplasminemia (ACERULOP) | Reactome | 2 / 2 | 235× | 1.77e-5 | 5.40e-4 ✓ sig. |
| Defective SLC40A1 causes hemochromatosis 4 (HFE4) (duodenum) | Reactome | 2 / 2 | 235× | 1.77e-5 | 5.40e-4 ✓ sig. |
| Scavenging of heme from plasma | Reactome | 3 / 13 | 54.3× | 2.00e-5 | 5.99e-4 ✓ sig. |
| Hormone signaling | KEGG | 6 / 219 | 6.5× | 3.12e-4 | 5.53e-3 ✓ sig. |
| African trypanosomiasis | KEGG | 3 / 37 | 19.1× | 5.06e-4 | 8.04e-3 ✓ sig. |
| Erythrocytes take up oxygen and release carbon dioxide | Reactome | 2 / 9 | 52.3× | 6.24e-4 | 9.49e-3 ✓ sig. |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| intracellular iron ion homeostasis | GO:0006879 | 16 / 71 | 82.6× | 1.98e-27 | 8.47e-24 ✓ sig. |
| multicellular organismal-level iron ion homeostasis | GO:0060586 | 13 / 28 | 170× | 3.20e-27 | 1.33e-23 ✓ sig. |
| iron ion transport | GO:0006826 | 10 / 31 | 118× | 3.81e-19 | 5.46e-16 ✓ sig. |
| response to iron ion | GO:0010039 | 7 / 18 | 142× | 2.28e-14 | 1.39e-11 ✓ sig. |
| cellular response to iron ion | GO:0071281 | 4 / 7 | 209× | 1.71e-9 | 3.61e-7 ✓ sig. |
| 'de novo' UMP biosynthetic process | GO:0044205 | 3 / 3 | 366× | 1.92e-8 | 3.01e-6 ✓ sig. |
| iron ion export across plasma membrane | GO:1903988 | 3 / 3 | 366× | 1.92e-8 | 3.01e-6 ✓ sig. |
| erythrocyte development | GO:0048821 | 5 / 32 | 57.3× | 2.36e-8 | 3.60e-6 ✓ sig. |
| response to hydrogen peroxide | GO:0042542 | 5 / 39 | 47.0× | 6.65e-8 | 8.62e-6 ✓ sig. |
| UDP biosynthetic process | GO:0006225 | 3 / 5 | 220× | 1.91e-7 | 2.08e-5 ✓ sig. |
| 'de novo' pyrimidine nucleobase biosynthetic process | GO:0006207 | 3 / 6 | 183× | 3.81e-7 | 3.72e-5 ✓ sig. |
| cellular oxidant detoxification | GO:0098869 | 5 / 66 | 27.8× | 9.76e-7 | 8.13e-5 ✓ sig. |
| pyrimidine nucleotide biosynthetic process | GO:0006221 | 3 / 9 | 122× | 1.59e-6 | 1.20e-4 ✓ sig. |
| acute-phase response | GO:0006953 | 4 / 37 | 39.6× | 3.04e-6 | 2.02e-4 ✓ sig. |
| transferrin transport | GO:0033572 | 3 / 11 | 99.9× | 3.11e-6 | 2.06e-4 ✓ sig. |